Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health, Inc. (ELV), with a market cap of $89.92 billion, is a leading health benefits company in the United States.

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Many stock analysts see Indianapolis-based Elevance’s recent struggles as an opportunity. Thirteen of 24 analysts tracked by The Wall Street Journal rate the health insurer as a buy.

In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these ...

Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” fourth quarter 2024 investor ...

Most readers would already know that Elevance Health's (NYSE:ELV) stock increased by 9.5% over the past three months. Since the market usually pay for a company’s long-term financial health, we ...

Elevance Health, Inc. (ELV), with a market ... the past six months and 24.2% over the past 52 weeks. Nevertheless, Wall Street analysts remain strongly bullish on ELV’s prospects.